Laurent Degos
#124,082
Most Influential Person Now
Laurent Degos's AcademicInfluence.com Rankings
Laurent Degosphilosophy Degrees
Philosophy
#5743
World Rank
#8633
Historical Rank
Logic
#2963
World Rank
#4048
Historical Rank
Laurent Degosbiology Degrees
Biology
#7720
World Rank
#10682
Historical Rank
Immunology
#422
World Rank
#438
Historical Rank
Download Badge
Philosophy Biology
Why Is Laurent Degos Influential?
(Suggest an Edit or Addition)Laurent Degos's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. (1995) (2179)
- The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus (1990) (1387)
- The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR (1991) (1373)
- All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. (1990) (1257)
- Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. (1998) (777)
- A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. (1999) (749)
- Acute promyelocytic leukemia. (1993) (712)
- All trans retinoic acid in acute promyelocytic leukemia (2001) (538)
- Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. (1997) (423)
- All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. (1995) (375)
- All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. (1990) (368)
- HISTOCOMPATIBILITY DETERMINANTS IN MULTIPLE SCLEROSIS (1974) (364)
- A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. (1990) (319)
- Retinoic Acid and Arsenic Synergize to Eradicate Leukemic Cells in a Mouse Model of Acute Promyelocytic Leukemia (1999) (299)
- Incidence, Clinical Features, and Outcome of AllTrans-Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic Leukemia (1998) (280)
- PML protein expression in hematopoietic and acute promyelocytic leukemia cells. (1993) (258)
- Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. (1990) (256)
- The PML growth-suppressor has an altered expression in human oncogenesis. (1995) (254)
- Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA regions (1990) (250)
- Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience. (2009) (250)
- Induction of the PML protein by interferons in normal and APL cells. (1995) (241)
- Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. (1993) (202)
- Expression and prognostic significance of survivin in de novo acute myeloid leukaemia (2000) (195)
- Small doses of ARA‐C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells? (1982) (188)
- Does treatment with ARA-C in low dosage cause differentiation of leukemic cells? (1983) (174)
- PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. (1994) (172)
- Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results. (2008) (168)
- Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group. (2006) (168)
- Letter: Histocompatibility determinants in multiple sclerosis. (1974) (164)
- Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia (2000) (163)
- Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. (1998) (162)
- Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87. (2000) (161)
- Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia. (2003) (154)
- Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (2006) (149)
- All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. (2001) (147)
- Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment. (1993) (146)
- Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid (1990) (146)
- Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells (1978) (145)
- Acute promyelocytic leukemia: biology and treatment. (1997) (143)
- Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cells. (1981) (140)
- Monoclonal Antibody to Human Platelet Glycoprotein I II. EFFECTS ON HUMAN PLATELET FUNCTION (1981) (140)
- Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome (2010) (138)
- Retinoid differentiation therapy in promyelocytic leukemia (1996) (136)
- Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. (2004) (135)
- Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group. (2005) (131)
- RETINOIC ACID THERAPY FOR PROMYELOCYTIC LEUKAEMIA (1989) (128)
- Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma. (2004) (126)
- Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR (2000) (122)
- Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia. (1994) (122)
- Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial (2000) (121)
- Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy (2002) (117)
- A PML/retinoic acid receptor alpha fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. (1992) (114)
- A haplotype study of HLA complex with special reference to the HLA-DR series and to Bf. C2 and glyoxalase I polymorphisms. (1978) (111)
- Dose Effect of Cis- and Trans-Encoded HLA-DQαβ Heterodimers in IDDM Susceptibility (1992) (111)
- Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients. (1992) (109)
- In Vivo Activation of cAMP Signaling Induces Growth Arrest and Differentiation in Acute Promyelocytic Leukemia (2002) (106)
- Human T cell gamma genes are frequently rearranged in B-lineage acute lymphoblastic leukemias but not in chronic B cell proliferations (1987) (103)
- The retinoic acid receptor alpha gene is rearranged in retinoic acid-sensitive promyelocytic leukemias. (1990) (102)
- Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation (2000) (101)
- Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility. (1992) (98)
- Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. (1991) (97)
- Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARα fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient (1999) (97)
- Valproic acid and all-trans retinoic acid for the treatment of elderly patients with acute myeloid leukemia. (2005) (90)
- Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study. (2004) (90)
- Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient. (1994) (86)
- Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylate (2004) (85)
- Treatment of acute promyelocytic leukaemia. (2001) (80)
- The PML-RARα gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells (1994) (77)
- All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells. (1991) (77)
- Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression. (1992) (74)
- Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience (2003) (74)
- PML-RARA–targeted DNA vaccine induces protective immunity in a mouse model of leukemia (2003) (73)
- The association of the HL-A antigens with diseases. (1974) (73)
- Low‐dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients (1985) (72)
- Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial. (2000) (70)
- Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial (2003) (70)
- In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy. (1995) (69)
- Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience (2005) (69)
- Treatment of acute promyelocytic leukemia by retinoids. (2007) (68)
- [Acute promyelocytic leukemia: retrospective study of 119 patients treated with daunorubicin]. (1984) (68)
- Differentiation therapy for acute promyelocytic leukemia. (1997) (68)
- Relationship between elevated levels of the alpha 1 acid glycoprotein in chronic myelogenous leukemia in blast crisis and pharmacological resistance to imatinib (Gleevec) in vitro and in vivo. (2003) (65)
- New approach to determination of specific functions of platelet membrane sites (1976) (64)
- Treatment of hairy cell leukemia with recombinant alpha interferon: I. Quantitative study of bone marrow changes during the first months of treatment. (1986) (64)
- All trans retinoic acid treatment for patients with acute promyelocytic leukemia. (1992) (63)
- Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cells (1986) (60)
- DNA binding of regulatory factors interacting with MHC‐class‐I gene enhancer correlates with MHC‐class‐I transcriptional level in class‐I‐defective cell lines (1991) (57)
- A molecular defect in thrombasthenic platelets. (1975) (57)
- Neutrophilic dermatoses during granulocytopenia. (1995) (56)
- Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C). (2003) (56)
- The human T-cell V gamma gene locus: cloning of new segments and study of V gamma rearrangements in neoplastic T and B cells (1988) (54)
- All-trans retinoic acid in relapsing malignant gliomas: clinical and radiological stabilization associated with the appearance of intratumoral calcifications (1997) (53)
- Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations. (2002) (52)
- Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment. (1999) (51)
- Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia (1994) (50)
- Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group. (2000) (50)
- The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells. (1994) (50)
- TCR γδ bearing T lymphocytes infiltrating human primary cutaneous melanomas (1992) (50)
- Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage. (1992) (49)
- Simultaneous occurrence of two rare cutaneous markers of poor prognosis in myelodysplastic syndrome: erythema elevatum diutinum and specific lesions (1994) (48)
- HLA DQB1*0301 allele is involved in the susceptibility to erythema multiforme. (1991) (48)
- Acquired IgG antibody occurring in a thrombasthenic patient: its effect on human platelet function (1978) (47)
- Correspondence analysis of HLA gene frequency data from 124 population samples. (1977) (47)
- Molecular defect in platelets from patients with bernard-soulier syndrome. (1977) (47)
- Adverse events in medicine: Easy to count, complicated to understand, and complex to prevent (2011) (46)
- The history of acute promyelocytic leukaemia (2003) (46)
- Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients (2014) (45)
- Treatment of leukemia with low dose Ara-C: a study of 159 cases. (1985) (45)
- HLA monoclonal antibody registry: a proposal. (2008) (44)
- Prominent expansion of circulating lymphocytes bearing gamma T-cell receptors, with preferential expression of variable gamma genes after allogeneic bone marrow transplantation. (1988) (44)
- SUCCESSFUL HAEMATOPOIETIC RECONSTITUTION USING AUTOLOGOUS PERIPHERAL BLOOD MONONUCLEATED CELLS IN A PATIENT WITH ACUTE PROMYELOCYTIC LEUKAEMIA (1986) (44)
- Treatment of leukemia with low-dose ara-C: a study of 160 cases. (1985) (43)
- In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome. (2001) (42)
- Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum- and nonplatinum-based chemotherapy: a retrospective subanalysis of two large, community-based trials. (2002) (42)
- Textbook of Malignant Haematology (1999) (42)
- Unexpected high incidence of intracranial subdural haematoma during intensive chemotherapy for acute myeloid leukaemia with a monoblastic component (1995) (41)
- H‐2 restriction for lymphocyte homing into lymph nodes (1979) (39)
- C8 deficiency in a family with xeroderma pigmentosum. Lack of linkage to the HLA region. (1977) (39)
- In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia. (1994) (39)
- Human T cell clones use a CD3-associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity. (1987) (38)
- LITHIUM IN ACUTE MYELOID LEUKÆMIA (1977) (38)
- Selective pressure on HL-A polymorphism (1974) (38)
- Structure-activity relationships of aromatic retinoids on the differentiation of the human histiocytic lymphoma cell line U-937. (1986) (38)
- All-trans retinoic acid rapidly decreases cathepsin G synthesis and mRNA expression in acute promyelocytic leukemia. (1996) (37)
- Induction of high-affinity GM-CSF receptors during all-trans retinoic acid treatment of acute promyelocytic leukemia. (1994) (37)
- Interferon alpha in the treatment of hairy cell leukemia (1986) (37)
- Identification of a Pure Splenic Form of Chronic Lymphocytic Leukaemia (1979) (37)
- c-myc and c-fos expression during interferon-alpha therapy for hairy cell leukemia. (1986) (37)
- TCR gamma delta bearing lymphocyte clones with lymphokine-activated killer activity against autologous leukemic cells (1989) (36)
- 1-B-D arabinofuranosyl cytosine and all-trans retinoic acid in combination accelerates and increases monocyte differentiation of myeloid leukemic cells. (1986) (36)
- Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils (1992) (36)
- [Treatment of acute promyelocytic leukemia by all trans retinoic acid]. (1995) (35)
- The V gamma locus of the human T cell receptor gamma gene. Repertoire polymorphism of the first variable gene segment subgroup (1988) (35)
- The "zero risk" concept for hospital-acquired infections: a risky business! (2009) (35)
- HLA-DRB1, DQA1 and DQB1 DNA polymorphisms in healthy Algerian and genetic relationships with other populations. (1994) (35)
- Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL Group. (1995) (35)
- Predominant expression of circulating CD3+ lymphocytes bearing gamma T cell receptor in a prolonged immunodeficiency after allogeneic bone marrow transplantation. (1988) (34)
- Acquired IgG antibody occurring in a thrombasthenic patient: its effect on human platelet function. (1978) (33)
- Regulation of transcription of the human T cell antigen receptor delta chain gene. A T lineage-specific enhancer element is located in the J delta 3-C delta intron (1990) (32)
- Long‐term follow‐up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patients (2013) (32)
- The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic. (1996) (31)
- Syndrome of neutrophil agranulocytosis, hypogammaglobulinemia, and thymoma (1982) (31)
- Hyperphosphorylation of CD20 in hairy cells. Alteration by low molecular weight B cell growth factor and IFN-alpha. (1991) (30)
- All-trans retinoic acid pharmacokinetics and bioavailability in acute promyelocytic leukemia: intracellular concentrations and biologic response relationship. (1995) (30)
- Distinct sensitivity of neuroblastoma cells for retinoid receptor agonists: evidence for functional receptor heterodimers (1997) (30)
- All-trans-retinoic acid treatment and retinoic acid receptor alpha gene rearrangement in acute promyelocytic leukemia: a model for differentiation therapy. (1992) (29)
- Selective induction of apoptosis in myeloid leukemic cell lines by monoacetone glucose-3 butyrate. (1994) (29)
- Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid. (1991) (29)
- [All-trans-retinoic acid in the treatment of acute promyelocytic leukemia]. (1990) (28)
- Proliferative response of hairy cells to B cell growth factor (BCGF): in vivo inhibition by interferon-alpha and in vitro effects of interferon-alpha, -beta, and -gamma. (1987) (28)
- Role in T-cell activation for HLA class I molecules from accessory cells: further distinction between activation signals delivered to T cells via CD2 and CD3 molecules. (1987) (28)
- Retinoic acids in the treatment of acute promyelocytic leukemia. (1990) (26)
- Structural organization of the hCTLA-1 gene encoding human granzyme B. (1990) (26)
- THE HLA‐DRB1*0405 HAPLOTYPE IS MOST STRONGLY ASSOCIATED WITH IDDM IN ALGERIANS (1992) (26)
- Differentiating agents in the treatment of leukemia. (1990) (26)
- Promyelocytic blast crisis of chronic myelocytic leukemia with both t(9;22) and t(15;17) in M3 cells (1984) (25)
- A "natural" anti-HLA-A2 antibody reacting with homozygous cells. (2008) (25)
- Intensive chemotherapy of hairy cell leukemia in patients with aggressive disease. (1985) (24)
- Activation of the CD3/T cell receptor (TcR) complex or of protein kinase C potentiate adenylyl cyclase stimulation in a tumoral T cell line: involvement of two distinct intracellular pathways (1991) (23)
- Identification of a novel 110-kilodalton structure expressed on a subset of T cell receptor-gamma delta-bearing cloned lymphocytes. (1990) (23)
- Retinoic acid in acute promyelocytic leukemia: a model for differentiation therapy (1992) (22)
- Treatment of acute promyelocytic leukemia with all-trans retinoic acid. (1991) (22)
- Low-dose cytarabine: persistence of a clonal abnormality during complete remission of acute nonlymphocytic leukemia. (1986) (22)
- Nucleotide sequence of the HLA-A26 class I gene: identification of specific residues and molecular mapping of public HLA class I epitopes. (1990) (22)
- Differentiation therapy in acute promyelocytic leukemia: European experience (1997) (22)
- Syndrome of neutrophil agranulocytosis, hypogammaglobulinemia, and thymoma. (1982) (21)
- In vitro treatment with retinoids or the topoisomerase inhibitor, VP-16, evidences different functional apoptotic pathways in acute promyelocytic leukemic cells. (1995) (21)
- TCR gamma delta bearing T lymphocytes infiltrating human primary cutaneous melanomas. (1992) (21)
- Phenotypic and genotypic heterogeneity in large granular lymphocyte expansion. (1987) (21)
- Is AraC Required In the Treatment of Standard Risk APL? Long Term Results of a Randomized Trial (APL 2000) From the French Belgian Swiss APL Group (2010) (21)
- Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials. (2014) (21)
- Detection of human B lymphocyte alloantigens by complement fixation. (1977) (20)
- Action of interferon-alpha on hairy cell leukemia: expression of specific receptors and (2'-5')oligo (A) synthetase in tumor cells from sensitive and resistant patients. (1988) (20)
- HLA class I molecules are associated with CD1a heavy chains on normal human thymus cells. (1988) (20)
- HLA-A,B,C, Bf and glyoxalase I polymorphisms in a sample of the Kabyle population (Algeria). (2008) (20)
- Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials) (2006) (20)
- The required interaction between monocytes and peripheral blood T lymphocytes (T‐PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T‐PBL subsets (1988) (20)
- Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO. (2000) (19)
- Human migrations and linkage disequilibrium ofHL-A system (1974) (18)
- Effect of cross reactions on HL-A antigen immunogenicity. (2008) (18)
- HLA-DP genotyping in HLA-A,B, and DR identical intrafamilial bone marrow transplantation. (1990) (18)
- Burkitt's lymphoma occurring 6 years after Hodgkin's disease. (1980) (18)
- All-trans retinoic acid (ATRA) therapeutical effect in acute promyelocytic leukemia. (1992) (18)
- Is acute promyelocytic leukemia a curable disease? Treatment strategy for a long-term survival. (1994) (17)
- Combined analysis of three studies of patients with Burkitt's lymphoma. (2008) (17)
- Biochemistry of HLA-DRw6: evidence for seven distinct haplotypes. (1986) (16)
- Molecular target-based treatment of human cancer: summary of the 10th international conference on differentiation therapy. (2005) (16)
- John Hughes Bennett, Rudolph Virchow... and Alfred Donné: the first description of leukemia. (2001) (16)
- Do Early Events Excluding Patients with Acute Promyelocytic Leukemia (APL) From Trial Enrollment Modify Treatment Result Evaluation? Real-Life Management of 100 Patients Referred to the University Hospital Saint-Louis Between 2000 and 2010. (2010) (16)
- Systemic vasculitis with bilateral perirenal haemorrhage in chronic myelomonocytic leukaemia (2000) (15)
- Interferon-alpha downregulates the abnormal intracytoplasmic free calcium concentration of tumor cells in hairy cell leukemia. (1992) (15)
- Breaking the mould in patient safety (2009) (15)
- Further Studies on a Specific Platelet Antibody Found in Bernard‐Soulier Syndrome and its Effects on Normal Platelet Function (1979) (15)
- Alpha‐interferon in hairy cell leukaemia: Direct effects on hairy cells or indirect cytotoxicity? (1987) (14)
- Simultaneous determination of all-trans and 13-cis retinoic acids and their 4-oxo metabolites by adsorption liquid chromatography after solid-phase extraction. (1995) (14)
- Regulation of Transcription of the Human T Cell Antigen Receptor S Chain Gene a T Lineage-specific Enhancer Element Is Located in the J63-c6 Intron (1990) (14)
- Reactivity of anti-HLA sera against mouse lymphocytes. (2008) (14)
- [The French National Authority for Health]. (2006) (14)
- Platelet acquired defect in PDGF and β thromboglobulin content in hairy cell leukaemia: improvement after interferon therapy (1987) (14)
- Histocompatibility antigens in two American Indian tribes of French Guiana. (1978) (14)
- HLA-DR, DQ, and Dw Relationships (1984) (14)
- Is ARAC Required in the Treatment of Newly Diagnosed APL? Results of a Randomized Trial (APL 2000). (2004) (13)
- Localization of the conformational alteration of MHC molecules induced by the association of mouse class I heavy chain with a xenogeneic beta 2-microglobulin. (1992) (13)
- Clinical activity of detorubicin: a new anthracycline derivative. (1979) (13)
- Epigenetic Therapy with 5-Azacitidine, Valproic Acid, and ATRA in Patients with High-Risk AML or MDS: Results of the French VIVEDEP Phase II Study (2008) (13)
- Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French‐Belgian‐Swiss APL group (2015) (13)
- Evidence for a new HLA class II determinant present on cells from HLA-DR1 and/or -DR4 individuals. (2008) (13)
- Differential uptake of all-trans retinoic acid by acute promyelocytic leukemic cells: evidence for its role in retinoic acid efficacy. (1995) (12)
- [HLA and diseases]. (1982) (12)
- G-CSF activates STAT pathways in Kasumi-1 myeloid leukemic cells with the t(8; 21) translocation: basis for potential therapeutic efficacy. (1997) (12)
- Suitability of three indicators measuring the quality of coordination within hospitals (2010) (12)
- Transcriptional regulation of the MHC class I HLA-A11 promoter by the zinc finger protein ZFX. (1996) (12)
- HLA-A, -B, and -DR antigens in North African patients with nasopharyngeal carcinoma. (1983) (12)
- Retinoic acid modulates RAR alpha and RAR beta receptors in human glioma cell lines. (1999) (12)
- Xanthomonas (formerly Pseudomonas) maltophilia--induced cellulitis in a neutropenic patient. (1992) (12)
- Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cells. (1986) (12)
- Treatment of acute promyelocytic leukaemia. (2001) (12)
- Can France keep its patients happy? (2008) (11)
- Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literature. (1987) (11)
- Differentiation therapy of leukemia. (1994) (11)
- TREATMENT OF ACUTE NON-LYMPHOBLASTIC LEUKAEMIA IN ELDERLY PATIENTS (1984) (11)
- Erythema multiforme is associated to HLA-Aw33 and DRw53. (1988) (11)
- Results of treating 53 hairy cell leukemia patients with alpha-interferon. (1987) (11)
- HLA-Cw7 and HBS Ag negative chronic active hepatitis. (1981) (11)
- ANALYSIS OF PRIMARY HLA‐SPECIFIC CYTOTOXIC T CELL RESPONSE IN GRAFT‐DRAINING LYMPH NODES— A TRANSGENIC MOUSE MODEL FOR IN VIVO RECOGNITION OF HUMAN MHC ANTIGENS (1991) (10)
- What is a T-cell clone? Effect of rIFN on T-cell clone function and T-cell receptor gene rearrangement. (1986) (10)
- 45. Regulation of BcI-2 and cell death by all-trans retinoic acid in acute promyelocytic leukemic cells (1992) (10)
- Characterization of nuclear retinoic acid binding activity in sensitive leukemic cell lines: cell specific uptake of ATRA and RAR alpha protein modulation. (1995) (10)
- Multiple nuclear factors bind to novel positive and negative regulatory elements upstream of the human MHC class I gene HLA-A11. (1994) (10)
- Hairy cell leukemia: follow-up after completion of alpha interferon treatment. (1989) (10)
- Acute undifferentiated myeloblastic leukemia revealed by specific hemorrhagic bullous lesions. (1993) (10)
- In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia. (1994) (10)
- Alteration of the PML proto-oncogene in leukemic cells does not abrogate expression of MHC class I antigens (1999) (10)
- Retinoids and differentiation treatment: a strategy for treatment in cancer. (1994) (9)
- HLA IN POPULATIONS: AN APPROACH FOR GENETICAL SUSCEPTIBILITY TO CANCER (1979) (9)
- Overcoming fragmentation of health research in Europe: lessons from COVID-19 (2020) (9)
- Induction treatment of acute promyelocytic leukemia using all-trans retinoic acid. Controversies about dosage, advantages and side-effect management. (1994) (9)
- Leukemic phase of malignant histiocytosis (arguments in favour of the histiomonocytic origin of the abnormal cells). (1979) (9)
- Treatment of newly diagnosed acute promyelocytic leukemia (APL) by a combination of all-trans retinoic acid (ATRA) and chemotherapy. French APL Group. (1994) (9)
- Annual guest lecture, Leukaemia Research Fund (UK): differentiation therapy and leukemia. (1993) (9)
- Transcriptional Regulation of the MHC Class I HLA-A11 Promoter by the Zinc Finger Protein ZFX (1996) (8)
- [History of acute promyelocytic leukemia]. (2015) (8)
- [Criteria for assessing granulocytic or platelet cytopenia caused by drugs. Results of consensus meetings]. (1987) (8)
- Human HLA-B27 Antigen in Transgenic Mice can Function as a Major Histocompatibility Antigen (1990) (8)
- Variations of HL-A antigens in populations (a survey). (1972) (8)
- Relative effectiveness assessment of listed drugs (REAL): A new method for an early comparison of the effectiveness of approved health technologies (2010) (8)
- HL-A and Burkitt's disease. (2008) (8)
- HLA antigens in 16 families with xeroderma pigmentosum. (2008) (8)
- HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies. (1989) (8)
- [HLA typing in classical and African Kaposi's disease]. (1986) (7)
- The t ( 15 ; 17 ) translocation alters the structure of a nuclear body in a RA-reversible fashion (7)
- PHARMACOKINETIC DATA ON VERY-LOW-DOSE CYTARABINE (1986) (7)
- Clinical investigation of lithium therapy in acute leukemia. (1980) (7)
- HL-A markers in the Vietnamese population. (1978) (7)
- Immune response to H-2 class I antigens on platelets. I. Immunogenicity of platelet class I antigens. (1988) (7)
- [Familial leukemia (author's transl)]. (1978) (7)
- Infiltrating lymphocytes in benign and malignant naevomelanocytic lesions. (1990) (7)
- Differentiating agents in the treatment of leukemia and myelodysplastic syndromes. (1990) (7)
- 6 Treatment of acute promyelocytic leukaemia (1996) (7)
- Alloantigens expressed on activated human T cells different from HLA-A, B, C, and DR antigens (2004) (7)
- Phase I trials in cancer treatment. The maximum tolerated dose: a barbarian guideline. (2000) (6)
- Changes in microrheology of acute promyelocytic leukemia cells during all-trans retinoic acid (ATRA) differentiation therapy: a mechanism for ATRA-induced hyperleukocytosis? (1995) (6)
- [Treatment of acute myeloblastic leukemia in elderly patients with low-dose cytosine arabinoside]. (1985) (6)
- Drug association including ara-C in myeloid leukemia cell differentiation: in vitro studies. (1985) (6)
- Viewing the safety imperative from the French policy perspective (2009) (6)
- Two faces of patient safety and care quality: a Franco-American comparison (2011) (6)
- Arsenic Trioxide (ATO) In the Consolidation Treatment of Newly Diagnosed APL - First Interim Analysis of a Randomized Trial (APL 2006) by the French Belgian Swiss APL Group (2010) (6)
- [Hematological toxicity of ticlopidine? (author's transl)]. (1982) (6)
- HL-A phenotyping in an Indonesian population. (2008) (5)
- Immunization with Fibroblasts Transfected with a Cloned Retroviral DNA Induces H-2 Specific Antibodies In Syngeneic Recipients (1988) (5)
- In vitro effects of retinoic acid. (1990) (5)
- H-2 typing of mice genetically selected for high or low antibody production (2005) (5)
- Interferon-a Downregulates the Abnormal Intracytoplasmic Free Calcium Concentration of Tumor Cells in Hairy Cell Leukemia (2003) (5)
- Sequential Treatment with 5-Azacytidine, Valproic Acid (VPA), and All-Trans Retinoic Acid (ATRA) in Patients with High-Risk Acute Myeloid Leukemia (AML). (2005) (5)
- A Combination of HLA-DQ , # Asp 57-Negative and HLA DQa Arg 52 Confers Susceptibility to Insulin-dependent Diabetes Mellitus (2013) (5)
- c-myc and c-fos expression during interferon-alpha therapy for hairy cell leukemia (1986) (5)
- Trans-encoded DQ alpha beta heterodimers confer susceptibility to myasthenia gravis disease. (1993) (5)
- Differentiation Therapy of Acute Promyelocytic Leukemia (1996) (5)
- [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia]. (1992) (5)
- Correlation between an HLA-DQα length polymorphism of messenger RNA and serologically defined specificities (DQwl, DRw53, DR3 + 5) (2004) (5)
- Molecular Dissection of DRw6 (1984) (5)
- Principal clinical features and prognosis in chronic lymphocytic leukemia. (1978) (4)
- Serological expression after sequential double transfection with purified HLA-11 gene of mouse fibroblasts carrying human beta-2 microglobulin (2004) (4)
- Late Relapses in APL Treated with ATRA and Anthracycline Based Chemotherapy: The European APL Group Experience (APL 91 and APL 93 Trials). (2005) (4)
- Studies of HLA-DR Antigens by Complement Fixation (1981) (4)
- Scientific Panel for Health: better research for better health (2016) (4)
- Retinoic acid receptors: involvement in acute promyelocytic leukemia. (1994) (4)
- A study of 22 anti-HLA-AW33 sera. (2008) (4)
- CT and MR patterns of spinal involvement in Richter syndrome. (1995) (4)
- Sendai Virus Infection of Tumor Cells Increases the Production of Autoreactive H-2 Specific Antibodies in Syngeneic Recipients (1988) (4)
- All trans retinoic acid as a targeting drug for differentiation therapy in acute promyelocytic leukemia. (1993) (4)
- Arsenic Trioxide (ATO) Or ATRA For Consolidation Treatment Of Standard Risk Non Elderly Newly Diagnosed APL– Second Interim Analysis Of a Randomized Trial (APL 2006) By The French Belgian Swiss APL Group (2013) (4)
- [A new concept: treatment using differentiation of the malignant cell in man]. (1995) (4)
- HLA -A, -B and -DR Antigens in North African Patients with Nasopharyngeal Carcinoma (2008) (3)
- All trans retinoic acid in acute promyelocytic leukemia. (2001) (3)
- Identification of a novel functional 85-kD glycoprotein restricted to long-term dividing human lymphocytic lines. (1993) (3)
- Final Workshop Report: HLA Class I RFLP (1989) (3)
- Double-blind, placebo-controlled lithium treatment in chemotherapy induced aplasia for AML: Reduced antibiotic requirement (1988) (3)
- The human T-cell V gamma gene locus: cloning of new segments and study of V gamma rearrangements in neoplastic T and B cells. (1988) (3)
- Immune response to H-2 class I antigens on platelets. II. Specific decrease of H-2 class I-specific antibody response induced by treatment with allogeneic platelets. (1988) (3)
- [Spontaneous perirenal haematoma occurring during 1 familial mediterranean fever. 3 cases (author's transl)]. (1979) (3)
- Intermolecular complexes between three human CD1 molecules on normal thymus cells (2004) (3)
- Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL): A Comparison between French -Belgian-Swiss and Spanish Results. (2005) (3)
- Human T lymphocyte clones with killer or natural killer activity. (1986) (3)
- Discrepancy between in vitro and in vivo passaged U-937 human leukemic cells: tumorigenicity and sensitivity to differentiating drugs. (1988) (3)
- Retinoids in Oncology (1995) (3)
- [Autografts of blood cells at various stages]. (1988) (3)
- Is acute promyelocytic leukemia a curable disease? Treatment strategy for a long-term survival. (1994) (3)
- Meeting report: the 11th International Conference on Differentiation Therapy and Innovative Therapeutics in Oncology. (2007) (2)
- All-trans Retinoic Acid Modulates the Retinoic Acid Receptor-a in Promyelocytic Cells (2003) (2)
- Letter to the editor: “growth hormone and acute promyelocytic leukemia” (1995) (2)
- Formal genetics of the HL-A region. (1975) (2)
- Hairy-cells are not lysed by NK-cells (1987) (2)
- Mouse cytotoxic T cells can recognize HLA-B27 antigen without H-2 restriction (2004) (2)
- Early Deaths (ED) in Acute Promyelocytic Leukemia (APL) in France: A Retrospective Multicenter Study in 355 Patients (pts) (2012) (2)
- [Clinical activity of m-Amsa and the combination of m-Amsa with cytosine arabinoside]. (1982) (2)
- Therapy in Newly Diagnosed Acute Promyelocytic Leukemia Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by (2014) (2)
- Jean Dausset a scientific pioneer: intuition and creativity for the patients (1916–2009) (2009) (2)
- Phenotypic reversion in acute promyelocytic leukemia. (1991) (2)
- Comparison of genetic (factorial correspondence analysis) and geographical distances. (1975) (2)
- Do we treat a disease or a patient? A subtle difference with dramatic consequences. (2000) (2)
- Allogeneic, autologous bone marrow transplantation and chemotherapy in first remission of adult acute lymphoblastic leukemia. Prospective study LALA87. Long term results (1999) (2)
- Granulocytic colony-stimulating factors (G-CSF and GM-CSF) in the treatment of adult acute myeloid leukemia. (1991) (2)
- [Treatment of acute leukemia by differentiation: effects of all trans retinoic acid in acute promyelocytic leukemia]. (1993) (2)
- Genetics of Human Populations (1978) (2)
- Molecular Cloning of an Inducible Cytotoxic T-Lymphocyte-Associated Gene (Hu-CTLA 1) and Gene Localization to Human Chromosome 14 (1989) (2)
- Recognition of HLA-B27 by mouse cytotoxic T-cell clones: a transgenic mouse (2004) (2)
- Clinical and Molecular Advances in Acute Promyelocytic Leukaemia (1995) (2)
- Extensive genomic polymorphism in mouse 21-hydroxylase region (2004) (2)
- The HL-A gene structure of Twareg populations. II. The Kel Dinig. (2008) (2)
- TCR gamma delta bearing lymphocyte clones with lymphokine-activated killer activity against autologous leukemic cells. (1989) (2)
- An oath for scientists as is The Hippocratic Oath for medical doctors. (2000) (2)
- Molecular localization to a unique DR beta-chain of the restriction element of an anti-influenza T cell clone. (1987) (2)
- Typing for HLA DQ using oligonucleotidic probes. (1990) (2)
- [A health system ill at ease with itself]. (2017) (1)
- [HLA complex and susceptibility to insulin-dependent diabetes]. (1990) (1)
- Differential Molecular Expression of HLA-DR and HLA-DQ Antigens in Leukemic Cells (1984) (1)
- HLA-Bw35 Antigen, Mitral Valve Prolapse and Blood Magnesium Level (1985) (1)
- Absence of interferon- receptors on hairy cells from a patient resistant to interferon- therapy (1987) (1)
- Studies on human Ia supertypic specificities by complement fixation on PHA blasts. I. Serological properties of DC1 specificity. (1983) (1)
- Approaches for an explanation of the differentiating effect of all trans retinoic acid in acute promyelocytic leukemia. (1992) (1)
- Les lymphocytes B (1987) (1)
- 107. The t(15;17) translocation of acute promyelocytic leukemia generates a functionally altered retinoic acid receptor (1992) (1)
- Acute promyelocytic leukemia, the retinoid paradox (1992) (1)
- Growth Factors in Elderly Patients with Acute Myeloid Leukemia (1998) (1)
- Prognosis and treatment of acute lymphoblastic leukemia (1978) (1)
- [Is the origin of cancer known?]. (1983) (1)
- [Improved results in the treatment of acute monoblastic leukemia: analysis of 91 patients treated in the 01 AM 81 protocol]. (1987) (1)
- Human CD3 gamma delta + activated lymphocytes exhibit killer activity in vitro against autologous leukemic cells. (1989) (1)
- Acute promyelocytic leukemia: A first model for multiple processes. (2001) (1)
- Presence of Thyroid-Stimulating Immunoglobulins (TSI) in DR3 Positive Normal Individuals (1984) (1)
- ALL Transretinoic Acid Followed by Intensive Chemotherapy in Newly Diagnosed Acute Promyelocytic Leukemia: A Pilot Study on 27 Cases (1994) (1)
- Role of the HLA system in anthropology: Application to an isolated population, the Kel Kummer tribe (1978) (1)
- [Differentiation of human malignant myeloid and lymphoid cells]. (1987) (1)
- Therapeutic complications in acute myelogenous leukemia. (1979) (1)
- A study of 15 anti-HLA-Bw16 sera. (2008) (1)
- Quantitative analysis of bone marrow changes during the treatment of hairy cell leukemia with interferon alpha. (1985) (1)
- Results of All-Trans Retinoic Acid Treatment in Acute Promyelocytic Leukemia (European Experience) (1997) (1)
- Trans-encoded DQαβ heterodimers confer susceptibility to myasthenia gravis disease (1994) (1)
- Descriptive serological analysis. (1975) (1)
- Differential expression of c-myc and c-fos oncogenes during the differentiation of human leukemic cells by Ara-C. (1987) (1)
- [Biological parameters of the efficiency of retinoic acid in acute leukemia]. (1991) (1)
- Real and apparent H-2-specific antibodies induced by syngeneic immunization (2006) (1)
- [Bone lesions in hairy cell leukaemia (author's transl)]. (1979) (1)
- Resistance to all-trans retinoic acid therapy in acute promyelocytic leukemia: in vitro studies (1994) (1)
- [Acute leukemia]. (1980) (1)
- Jean Bernard. Medicine, science, humanity. (2006) (1)
- Specificity of an Acquired Antiplatelet Antibody Occuring in a Polytransfused Thrombasthenic Patient (1975) (1)
- [Results of a study of the relationship between the number of pregnancies and the occurrence of acute myeloblastic leukemia]. (1971) (1)
- Involvement of the H-2 Complex in Steroid Hormone Metabolism (1987) (1)
- A Role for HLA-Class I Molecules from Accessory Cells in T-Cell Activation (1988) (0)
- In Vitro Differentiation of a Human Thymic Clone Coexpressing CD4 and CD8 Molecules (1989) (0)
- [Principles of immunogenetics. HLA and diseases]. (1980) (0)
- [Leukemias. Fundamental data. Epidemiology of acute human leukemia. The risk of acute leukemia]. (1973) (0)
- Antibodies as a Cause for Platelet Functional Defects (1977) (0)
- La région chromosomique HLA (1986) (0)
- [Refractory anemia with partial blastosis. A new therapeutic approach]. (1989) (0)
- How to limit the overabundance of health care administrators. (2001) (0)
- Subdivision of DRw6 by Influenza-Specific Proliferative Cloned Cell Lines (1984) (0)
- Is there a limit to the normality of blood products? (2000) (0)
- [Malignant histiocytosis of pulmonary form]. (1986) (0)
- α-IFN treatment does not induce Ki-ras expression in hairy-cell leukemia patients (1989) (0)
- Combined T reatment W ith A rsenic T rioxide a nd A ll-Trans- Retinoic A cid i n P atients W ith R elapsed A cute Promyelocytic L eukemia (2003) (0)
- [HLA and liver disease]. (1980) (0)
- Predictive factors of diagnostic and therapeutic divergence in a nationwide cohort of patients seeking second medical opinion (2021) (0)
- Modulation of allogenic reaction by ticlopidine treatment. (1991) (0)
- Myasthenia gravis is associated with two DQ alpha/beta heterodimers. (1993) (0)
- How to compensate for the expense of new drugs. (2001) (0)
- [Is the polymorphism of the HL-A system maintained by a disadvantage of the homozygotes?]. (1973) (0)
- [Phorbol diester induces phenotypic and functional changes in human T-lymphocyte clones]. (1985) (0)
- Rapid Publication (0)
- [Self-medication, patients as actors in their own health]. (2007) (0)
- Production of a monoclonal antibody (2B44) reactive on a shared epitope on dendritic reticulum cells, smooth muscle cells of vessels and Reed-Sternberg cells. (1991) (0)
- [Kinetics of the appearance of HLA-DR antigens on human alloactivated T lymphocytes and the demonstration of new antigenic determinants]. (1980) (0)
- One moral, many ethics. (2001) (0)
- Retinoids as a model of differentiating drugs in malignancies (1993) (0)
- [Implication of HLA class I molecule from monocyte in T-cell activation by CD2 or CD3 monoclonal antibodies]. (1987) (0)
- [HLA and cancer]. (1992) (0)
- Change in the Fine Specificity of a Human Cytotoxic T Cell Clone Under α-Interferon Treatment (1989) (0)
- IMPROVEMENT OF BASI TREATMENT PRESCRIBED AT DISCHARGE FOR MI PATIENTS: RESULTS OF THE FRENCH NATIONAL PERFORMANCE MEASURE ASSESSMENT (2011) (0)
- [HLA and myasthenia. Subdivision in 3 categories]. (1985) (0)
- [Managing conflicts of interest for more confidence]. (2010) (0)
- [Treatment through malignant cell differentiation. Effect of retinoid in acute promyelocytic leukemia seems promising]. (1991) (0)
- [Tricholeukocytic leukemia with monoclonal IgG K]. (1980) (0)
- [Gametic association in the HL-A chromosomal region (an argument in favor of gene flow by migration)]. (1973) (0)
- Treatment Strategy of Acute Promyelocytic Leukemia Using All Trans Retinoic Acid (1994) (0)
- ORGANIZATION, DIVERSITY AND REARRANGEMENT OF THE HUMAN T-CELL REARRANGING GAMMA-GENES (1986) (0)
- [Confronted to medical error, emphasize its positive aspects]. (2015) (0)
- Concise summary of the cytokines involved in human hematopoiesis (2004) (0)
- 158. Strategy for the treatment of acute promyelocytic leukemia combining differentiation agent and cytotoxic drugs (1992) (0)
- [Genetic and immunologic factors in human leukemogenesis]. (1970) (0)
- [Thrombocytopenic purpura during heparinotherapy. Two cases (author's transl)]. (1979) (0)
- Are we building a new Tower of Babel? (2001) (0)
- promyelocytic leukemia. I. Clinical results (see comments) All-trans retinoic acid as a differentiation therapy for acute (2011) (0)
- [Post-hepatitic bone marrow aplasia]. (1971) (0)
- Restriction analysis of influenza-specific cloned cell lines issued from an HLA-DRw6/DR- donor (2004) (0)
- [Reduction or increase in treatment of acute lymphoblastic leukemia in children. The treatment of forms with a good prognosis and the treatment of forms with very high risk]. (1985) (0)
- Textbook of Malignant Haematology, Second Edition (2004) (0)
- Reactivity of anti-hla sera against mouse lymphoyctes. Abstr. (1976) (0)
- HLA DQ alpha/beta molecule associated with the susceptibility to insulin-dependent diabetes mellitus. A model for HLA/autoimmune disease association. (1990) (0)
- treatment Quantitative study of bone marrow changes during the first months of Treatment of hairy cell leukemia with recombinant alpha interferon: I. (2011) (0)
- [The preleukemic thrombopenias. (Apropos of 3 cases)]. (1971) (0)
- Drug composition for the treatment and prevention of diseases due to cell-mediated cytotoxicity comprising at least one pyridine derivative as active ingredient (1987) (0)
- H‐2 INFLUENCE ON THE PRODUCTION OF REAL BUT NOT OF APPARENT H‐2‐SPECIFIC ANTIBODIES INDUCED BY THE ASSOCIATION OF SYNGENEIC CLASS I HEAVY CHAINS WITH BOVINE β2‐MICROGLOBULIN (1991) (0)
- Synopsis of the discussions of the workshop: hematology. (1994) (0)
- Xenogeneic monoclonal HLA-specific antibodies defining mouse lymphocyte determinants encoded by the H-2 complex (2004) (0)
- [Current findings on acute leukemia]. (1986) (0)
- Treatment of Adult Acute Lymphoblastic Leukemia Long Term Results of a Prospective Study: LALA 87 (2001) (0)
- [Treatment of malignant tumors by interleukin 2 and LAK cells]. (1988) (0)
- Molecular approaches to the relationships between HLA and susceptibility to diseases. (1992) (0)
- Persistance of loss of the Y chromosome during long-lasting complete remission in a case of acute myelogenous leukemia treated with low-dose cytosine arabinoside (1986) (0)
- Pharmaceutical compositions increasing camp useful for the treatment of cancers (2003) (0)
- [New biomodulator treatment, treatment with interferon alpha in hematology and treatment using interleukin 2]. (1988) (0)
- Therapy Related APL (tAPL). Prospective Analysis of Etiological Factors In Recent Cases, and Comparison with De Novo Cases (2010) (0)
- Structural Mapping of T Cell Clones Restriction Elements Suggests That a DQα-DRβ Hybrid Molecule Could Be Functional in DRw13 Cells (1989) (0)
- comparison of French-Belgian-Swiss and PETHEMA results Treatment of newly diagnosed acute promyelocytic leukemia (APL): a (2013) (0)
- Molecular genetics of acute promyelocytic leukemia: the t(15,17) translocation (2009) (0)
- Autologous Stem Cell Transplantation in Acute Promyelocytic Leukemia Patients Achieving a Second Complete Remission (2000) (0)
- Occurrence ofT-Cell Features in a Child's Lymphoproliferative Disorder1 (1984) (0)
- [Immunotherapy of malignant melanoma]. (1990) (0)
- [Jean Dausset. Pioneer, discoverer and responsible]. (2009) (0)
- J. M. Paulus: Production et Destruction des Plaquettes Sanguines. (1976) (0)
- "Growth hormone and acute promyelocytic leukemia". (1995) (0)
- Interferon-α in hairy cell leukemia: A direct action on leukemic cells (1987) (0)
- [Retinoid receptors and hematologic diseases]. (1994) (0)
- Subject Index, Vol. 63, 1980 (1980) (0)
- vivo down-regulation of alpha interferon receptors on tumor cells Treatment of hairy cell leukemia with recombinant alpha interferon: II. In (2011) (0)
- Retinoids in Oncology: Conclusions and Future Directions (1995) (0)
- [Relationship between the number of pregnancies and the risk of acute leukemia]. (1970) (0)
- Isolation from the Human MHC of a Class I Gene Encoding a Nonubiquitous Antigen Expressed on Activated Cells (1989) (0)
- Conflicts of interest. (2001) (0)
- [Discovery of the HLA system]. (1999) (0)
- HODGKIN'S DISEASE (1967) (0)
- [HLA and diseases]. (1989) (0)
- [Developing health services research in France, one of the HAS missions]. (2008) (0)
- [The HLA system: theoretical and epidemiological data. A critical study of its application in pathology]. (1987) (0)
- [Hairy cell leukemia. Current therapeutic data on interferon]. (1987) (0)
- Cloning and Expression of the Gene Encoding HLA-A11 (1984) (0)
- [The chromosomal HLA region]. (1986) (0)
- Reactivity of anti-HLA sera against mouse lymphocytes [proceedings]. (1976) (0)
- [Absence of class I HLA antigen in acute myeloblastic leukemia]. (1988) (0)
- Precise Location of HLA Genes on Chromosome 6 (1984) (0)
- [Subacute myelo-monocytic leukemia. Cyto- and biochemical study of granulocytic and monocytic lines]. (1972) (0)
- Contribution of Modern Biology to Medicine, Vertazzoni Bollun, Gauone (Eds.). Raven Press, New York (1985) (1986) (0)
- 105. Function of normal and latered retinoic acid binding proteins in acute promyelocytic leukemia (1992) (0)
- Immunization with Fibroblasts Expressing Human β 2 -Microglobulin Induces H-2 Specific Antibodies in Syngeneic Recipients (1988) (0)
- [The HLA system. Relations with pathology]. (1984) (0)
- DR and DQ a and ß Polymorphism in DRw13- and DRw52 +-Related Haplotypes (1989) (0)
- Antigen Report: New HLA-DR (1984) (0)
- [Caring for a patient and not a disease isolated in its context]. (2002) (0)
- Book Review/Varia (1976) (0)
- Title Page / Table of Contents, Suppl. 1, 1996 (1996) (0)
- [Malignant histiocytosis. Remission for more than 5 years]. (1990) (0)
- Selected lineage-associated antigens in hematopoietic cells (2004) (0)
- Nomenclature for factors of the HLA system. Comments to the nomenclature committee. (1989) (0)
- Contents, Vol. 63, 1980 (1980) (0)
- [Treatment of acute leukemia]. (1985) (0)
- [Future vision of haematology]. (2004) (0)
- PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY (PML) ASSOCIATED WITH B-CELL CHRONIC LYMPHOID LEUKEMIA (CLL) INFILTRATION OF THE BRAIN AND CEREBRAL LATENT EBV INFECTION (1993) (0)
- [Role of the HLA system in biology and pathology]. (1979) (0)
- International Vision of Big Data (2020) (0)
- [From graft to histocompatibility]. (1993) (0)
- Clinical Results of All Trans Retinoic Acid (1995) (0)
- Medical practice is actually dictated by lawyers. (2000) (0)
- [Genetic markers and disease susceptibility (author's transl)]. (1979) (0)
- ATRA THERAPY IN ACUTE PROMYELOCYTIC LEUKEMIA A MODEL FOR DIFFERENTIATION THERAPY (1993) (0)
- 108. PML: a new zinc finger protein involved in the t(15;17) translocation of acute promyelocytic leukemia (1992) (0)
- Syndrome of Neutrophil Agranulocytosis , Hypogammaglobulinemia , and (2005) (0)
- study of V gamma rearrangements in neoplastic T and B cells The human T-cell V gamma gene locus: cloning of new segments and (2011) (0)
- Acquired Resistance to All-Trans Retinoic Acid Therapy in Acute Promyelocytic Leukemia (1996) (0)
- 1. All trans retinoic acid as a targeting drug for differentiation therapy in acute promyelocytic leukemia (0)
- [New perspectives in the treatment of cancer]. (1989) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Laurent Degos?
Laurent Degos is affiliated with the following schools:
